Investigation of Flare and Remission in Subjects With Atopic Dermatitis

NCT03710044 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic decision

Conditions

Atopic Dermatitis

Interventions

DRUG: Cyclosporine A

Sponsor

LEO Pharma